ANIXA BIOSCIENCES, INC. Preferred Stock, Value, Issued
ANIXA BIOSCIENCES, INC. (ANIX) had Preferred Stock, Value, Issued of $14.00 thousand as of 2016-10-31, per its 10-K filed 2018-01-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2018-01-09
- 2016-10-31: Preferred Stock, Value, Issued $14.00K.
- 2016-07-31: Preferred Stock, Value, Issued $14.00K.
- 2016-04-30: Preferred Stock, Value, Issued $14.00K.
- 2016-01-31: Preferred Stock, Value, Issued $14.00K.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Value, Issued as first filed |
|---|---|---|
| 2016-10-31 | $14.00K 10-K · filed 2018-01-09 | |
| 2016-07-31 | $14.00K 10-Q · filed 2016-08-19 | |
| 2016-04-30 | $14.00K 10-Q · filed 2016-05-20 | |
| 2016-01-31 | $14.00K 10-Q · filed 2016-02-19 | |
| 2015-10-31 | $14.00K 10-K · filed 2016-12-08 | |
| 2015-07-31 | $14.00K 10-Q · filed 2015-08-18 | |
| 2015-04-30 | $350.00K 10-Q · filed 2015-05-22 | |
| 2015-01-31 | $350.00K 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $14.00K 10-K · filed 2015-12-23 | $350.00K 10-K · filed 2015-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |